Click for best price
Migraine With Brainstem Aura Drugs Market Size, Share 2022
A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occur in men and women of all ages.
This report contains market size and forecasts of Migraine With Brainstem Aura Drugs in Global, including the following market information:
Global Migraine With Brainstem Aura Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Migraine With Brainstem Aura Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Abortive Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Migraine With Brainstem Aura Drugs include Pfizer, GlaxoSmithKline, Abbott Laboratories, Eli Lily, Johnson & Johnson, AstraZeneca, Eisai, Allergen and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Migraine With Brainstem Aura Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Migraine With Brainstem Aura Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, by Type, 2021 (%)
Abortive Medication
Preventive Medication
Global Migraine With Brainstem Aura Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Others
Global Migraine With Brainstem Aura Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Migraine With Brainstem Aura Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Migraine With Brainstem Aura Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Migraine With Brainstem Aura Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
Abbott Laboratories
Eli Lily
Johnson & Johnson
AstraZeneca
Eisai
Allergen
Merck
Endo International
Impax Laboratories
| Report Attributes |
Report Details |
| Report Title |
Migraine With Brainstem Aura Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Migraine With Brainstem Aura Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Migraine With Brainstem Aura Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Migraine With Brainstem Aura Drugs Overall Market Size
2.1 Global Migraine With Brainstem Aura Drugs Market Size: 2021 VS 2028
2.2 Global Migraine With Brainstem Aura Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Migraine With Brainstem Aura Drugs Players in Global Market
3.2 Top Global Migraine With Brainstem Aura Drugs Companies Ranked by Revenue
3.3 Global Migraine With Brainstem Aura Drugs Revenue by Companies
3.4 Top 3 and Top 5 Migraine With Brainstem Aura Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Migraine With Brainstem Aura Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Migraine With Brainstem Aura Drugs Players in Global Market
3.6.1 List of Global Tier 1 Migraine With Brainstem Aura Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Migraine With Brainstem Aura Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Migraine With Brainstem Aura Drugs Market Size Markets, 2021 & 2028
4.1.2 Abortive Medication
4.1.3 Preventive Medication
4.2 By Type - Global Migraine With Brainstem Aura Drugs Revenue & Forecasts
4.2.1 By Type - Global Migraine With Brainstem Aura Drugs Revenue, 2017-2022
4.2.2 By Type - Global Migraine With Brainstem Aura Drugs Revenue, 2023-2028
4.2.3 By Type - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Migraine With Brainstem Aura Drugs Market Size, 2021 & 2028
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Others
5.2 By Application - Global Migraine With Brainstem Aura Drugs Revenue & Forecasts
5.2.1 By Application - Global Migraine With Brainstem Aura Drugs Revenue, 2017-2022
5.2.2 By Application - Global Migraine With Brainstem Aura Drugs Revenue, 2023-2028
5.2.3 By Application - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Migraine With Brainstem Aura Drugs Market Size, 2021 & 2028
6.2 By Region - Global Migraine With Brainstem Aura Drugs Revenue & Forecasts
6.2.1 By Region - Global Migraine With Brainstem Aura Drugs Revenue, 2017-2022
6.2.2 By Region - Global Migraine With Brainstem Aura Drugs Revenue, 2023-2028
6.2.3 By Region - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Migraine With Brainstem Aura Drugs Revenue, 2017-2028
6.3.2 US Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.3.3 Canada Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.3.4 Mexico Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Migraine With Brainstem Aura Drugs Revenue, 2017-2028
6.4.2 Germany Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4.3 France Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4.4 U.K. Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4.5 Italy Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4.6 Russia Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.4.8 Benelux Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Migraine With Brainstem Aura Drugs Revenue, 2017-2028
6.5.2 China Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.5.3 Japan Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.5.4 South Korea Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.5.6 India Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Migraine With Brainstem Aura Drugs Revenue, 2017-2028
6.6.2 Brazil Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.6.3 Argentina Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue, 2017-2028
6.7.2 Turkey Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.7.3 Israel Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Migraine With Brainstem Aura Drugs Market Size, 2017-2028
6.7.5 UAE Migraine With Brainstem Aura Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Migraine With Brainstem Aura Drugs Major Product Offerings
7.1.4 Pfizer Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Migraine With Brainstem Aura Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Migraine With Brainstem Aura Drugs Major Product Offerings
7.3.4 Abbott Laboratories Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.3.5 Abbott Laboratories Key News
7.4 Eli Lily
7.4.1 Eli Lily Corporate Summary
7.4.2 Eli Lily Business Overview
7.4.3 Eli Lily Migraine With Brainstem Aura Drugs Major Product Offerings
7.4.4 Eli Lily Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.4.5 Eli Lily Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Migraine With Brainstem Aura Drugs Major Product Offerings
7.5.4 Johnson & Johnson Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Migraine With Brainstem Aura Drugs Major Product Offerings
7.6.4 AstraZeneca Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Eisai
7.7.1 Eisai Corporate Summary
7.7.2 Eisai Business Overview
7.7.3 Eisai Migraine With Brainstem Aura Drugs Major Product Offerings
7.7.4 Eisai Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.7.5 Eisai Key News
7.8 Allergen
7.8.1 Allergen Corporate Summary
7.8.2 Allergen Business Overview
7.8.3 Allergen Migraine With Brainstem Aura Drugs Major Product Offerings
7.8.4 Allergen Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.8.5 Allergen Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Migraine With Brainstem Aura Drugs Major Product Offerings
7.9.4 Merck Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 Endo International
7.10.1 Endo International Corporate Summary
7.10.2 Endo International Business Overview
7.10.3 Endo International Migraine With Brainstem Aura Drugs Major Product Offerings
7.10.4 Endo International Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.10.5 Endo International Key News
7.11 Impax Laboratories
7.11.1 Impax Laboratories Corporate Summary
7.11.2 Impax Laboratories Business Overview
7.11.3 Impax Laboratories Migraine With Brainstem Aura Drugs Major Product Offerings
7.11.4 Impax Laboratories Migraine With Brainstem Aura Drugs Revenue in Global Market (2017-2022)
7.11.5 Impax Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Migraine With Brainstem Aura Drugs Market Opportunities & Trends in Global Market
Table 2. Migraine With Brainstem Aura Drugs Market Drivers in Global Market
Table 3. Migraine With Brainstem Aura Drugs Market Restraints in Global Market
Table 4. Key Players of Migraine With Brainstem Aura Drugs in Global Market
Table 5. Top Migraine With Brainstem Aura Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Migraine With Brainstem Aura Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Migraine With Brainstem Aura Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Migraine With Brainstem Aura Drugs Product Type
Table 9. List of Global Tier 1 Migraine With Brainstem Aura Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Migraine With Brainstem Aura Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Migraine With Brainstem Aura Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Migraine With Brainstem Aura Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Migraine With Brainstem Aura Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Migraine With Brainstem Aura Drugs Product Offerings
Table 32. Pfizer Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Migraine With Brainstem Aura Drugs Product Offerings
Table 35. GlaxoSmithKline Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Abbott Laboratories Corporate Summary
Table 37. Abbott Laboratories Migraine With Brainstem Aura Drugs Product Offerings
Table 38. Abbott Laboratories Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lily Corporate Summary
Table 40. Eli Lily Migraine With Brainstem Aura Drugs Product Offerings
Table 41. Eli Lily Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Migraine With Brainstem Aura Drugs Product Offerings
Table 44. Johnson & Johnson Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Migraine With Brainstem Aura Drugs Product Offerings
Table 47. AstraZeneca Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Eisai Corporate Summary
Table 49. Eisai Migraine With Brainstem Aura Drugs Product Offerings
Table 50. Eisai Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Allergen Corporate Summary
Table 52. Allergen Migraine With Brainstem Aura Drugs Product Offerings
Table 53. Allergen Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Migraine With Brainstem Aura Drugs Product Offerings
Table 56. Merck Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Endo International Corporate Summary
Table 58. Endo International Migraine With Brainstem Aura Drugs Product Offerings
Table 59. Endo International Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Impax Laboratories Corporate Summary
Table 61. Impax Laboratories Migraine With Brainstem Aura Drugs Product Offerings
Table 62. Impax Laboratories Migraine With Brainstem Aura Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Migraine With Brainstem Aura Drugs Segment by Type in 2021
Figure 2. Migraine With Brainstem Aura Drugs Segment by Application in 2021
Figure 3. Global Migraine With Brainstem Aura Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Migraine With Brainstem Aura Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Migraine With Brainstem Aura Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Migraine With Brainstem Aura Drugs Revenue in 2021
Figure 8. By Type - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 12. US Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 24. China Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Migraine With Brainstem Aura Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Migraine With Brainstem Aura Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abbott Laboratories Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lily Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eisai Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Allergen Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Endo International Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Impax Laboratories Migraine With Brainstem Aura Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
